BioXcel Therapeutics (BTAI)
(Delayed Data from NSDQ)
$0.61 USD
-0.02 (-3.57%)
Updated Aug 30, 2024 03:59 PM ET
After-Market: $0.62 +0.01 (1.22%) 4:18 PM ET
2-Buy of 5 2
F Value C Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/12/24 |
---|---|
Current Quarter | -0.45 |
EPS Last Quarter | -0.21 |
Last EPS Surprise | 72.37% |
ABR | 2.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.84 |
Next Year | -1.45 |
EPS (TTM) | -3.56 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.29M | 1.49M | 4.47M | 8.81M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 1.29M | 1.49M | 4.47M | 8.81M |
Low Estimate | 1.29M | 1.49M | 4.47M | 8.81M |
Year ago Sales | 0.34M | 0.38M | 1.38M | 4.47M |
Year over Year Growth Est. | 279.41% | 292.11% | 223.92% | 97.09% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.45 | -0.37 | -1.84 | -1.45 |
# of Estimates | 2 | 1 | 2 | 2 |
Most Recent Consensus | -0.44 | -0.37 | -1.76 | -1.27 |
High Estimate | -0.44 | -0.37 | -1.76 | -1.27 |
Low Estimate | -0.45 | -0.37 | -1.91 | -1.63 |
Year ago EPS | -1.72 | -0.76 | -6.15 | -1.84 |
Year over Year Growth Est. | 73.84% | 51.32% | 70.08% | 20.92% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 2 | 2 |
Up Last 60 Days | 1 | 1 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.45 | -0.37 | -1.84 | -1.45 |
7 Days Ago | -0.45 | -0.37 | -1.84 | -1.45 |
30 Days Ago | -0.65 | -0.59 | -2.74 | -1.75 |
60 Days Ago | -0.65 | -0.59 | -2.61 | -1.86 |
90 Days Ago | -0.65 | -0.59 | -2.61 | -1.86 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.45 | -0.37 | -1.84 | -1.45 |
Zacks Consensus Estimate | -0.45 | -0.37 | -1.84 | -1.45 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.21 | -0.87 | -0.76 | -1.72 | NA |
Estimate | -0.76 | -0.68 | -0.98 | -1.29 | NA |
Difference | 0.55 | -0.19 | 0.22 | -0.43 | 0.04 |
Surprise | 72.37% | -27.94% | 22.45% | -33.33% | 8.39% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more